Merck & Co. Spears Another Acquisition With Harpoon

 
• By Jessica Merrill

Merck & Co. opened the J.P. Morgan Healthcare Conference with news that it will acquire the cancer drug developer Harpoon Therapeutics for approximately $680m.

fish
Merck nabbed Harpoon in an acquisition • Source: Shutterstock

More from Anticancer

More from Therapy Areas